[gnso-gac-closed-generics] Following up (Re: FOR YOUR REVIEW: Draft timeline for completion of Closed Generics dialogue work)

Thu Apr 6 20:03:58 UTC 2023

Hi Mary,

First, I think it makes sense for the two ICANN77 sessions to be open for observers to attend. Does this mean that there are plans to release the recordings and mailing list once an initial Framework is shared with the community? This would align with the logic of having the ICANN77 sessions being open.

Second, thanks to all Staff for preparing the timeline. Can you please confirm that we are able to share this timeline with our groups?

Thanks,
Sophie

Sophie Hey
she/her
Policy Advisor
Com Laude
T +44 (0) 20 7421 8250
Ext 252

[cid:image002.png at 01D968CB.41412B20]<https://comlaude.com/>

Easter Holiday

The Com Laude Group UK and Spanish offices will close from Friday 7th of April 2023, reopening on Tuesday the 11th of April 2023.

Please send your urgent requests to admin at comlaude.com as this is the email box which the team providing cover will be checking and don't forget to copy in your Domain Strategists.

We will also continue to provide 24/7 monitoring of our services and servers and emergency cover in the event that you have a critical requirement outside of our "follow the sun" office hours. Please call our emergency helpline on one of the following numbers in such circumstances - UK: +44 (0) 20 82313 5922, USA: +1 2064877683

From: gnso-gac-closed-generics <gnso-gac-closed-generics-bounces at icann.org> On Behalf Of Mary Wong
Sent: Tuesday, April 4, 2023 6:03 PM
To: gnso-gac-closed-generics at icann.org
Subject: [gnso-gac-closed-generics] Following up (Re: FOR YOUR REVIEW: Draft timeline for completion of Closed Generics dialogue work)

Hello again everyone,

To follow up on the draft timeline we circulated yesterday, the staff team thought you’d like to know that our colleagues who support each of your groups are coordinating on ICANN77 scheduling and will be requesting the two sessions at ICANN77 that I referenced below. In this regard, the staff team would like to seek your view as to whether these two sessions will be closed to observers, or whether – given, especially, the fact that by that time the draft Framework will have already been publicly distributed and community input hopefully received – they ought to be open to observers to attend.

By way of background, as some of you know, the community’s preference for ICANN Public Meetings is that by “default” as many community sessions as possible are open rather than closed. “Open” sessions can take a variety of forms, depending on the purpose of the sessions, and can include – as is the case with many GAC and GNSO Council meetings – providing speaking rights only to group members and invited guests.

We hope that the above information is useful as you review the draft timeline, which the staff team assumes you will also be sharing with your respective community leadership teams for their information and planning purposes. Please do let us know your view as to whether to conduct the two proposed ICANN77 sessions as open ones. Thank you!

Cheers
Mary (on behalf of Melissa Peters Allgood and the staff team supporting this Facilitated Dialogue)

From: Mary Wong <mary.wong at icann.org<mailto:mary.wong at icann.org>>
Date: Monday, April 3, 2023 at 4:18 PM
To: "gnso-gac-closed-generics at icann.org<mailto:gnso-gac-closed-generics at icann.org>" <gnso-gac-closed-generics at icann.org<mailto:gnso-gac-closed-generics at icann.org>>
Subject: FOR YOUR REVIEW: Draft timeline for completion of Closed Generics dialogue work

Dear all,

With thanks to Terri for scheduling the rest of our April calls in her usual efficient way, please find attached the proposed timeline that the staff team presented on the call earlier today.

As we mentioned on the call, staff has not shared this timeline with anyone outside the dialogue group. However, our understanding is that the GNSO Council leadership will greatly appreciate an initial Framework being circulated for community input prior to its 15 May meeting, where it will likely begin discussing a potential timeline and project plan for the subsequent policy work to come.

We have endeavored to incorporate your feedback from last week’s call, including building in a limited number of meetings following the provision of community input for the group to meet, to discuss whether specific clarifications to the Framework may be necessary. This includes two sessions that the staff team will request on your behalf during ICANN77. We have also added time and flexibility for the ALAC and the GAC to perform a final review and sign-off on the Framework after the GNSO Council submits an initial policy timeline and plan to the Board on 15 June.

We hope this proposed timeline is feasible and meets your group’s needs and expectations. Thank you!

Cheers
Mary (on behalf of Melissa Peters Allgood and the staff team supporting this Facilitated Dialogue)
________________________________
The contents of this email and any attachments are confidential to the intended recipient. They may not be disclosed, used by or copied in any way by anyone other than the intended recipient. If you have received this message in error, please return it to the sender (deleting the body of the email and attachments in your reply) and immediately and permanently delete it. Please note that Com Laude Group Limited (the “Com Laude Group”) does not accept any responsibility for viruses and it is your responsibility to scan or otherwise check this email and any attachments. The Com Laude Group does not accept liability for statements which are clearly the sender's own and not made on behalf of the group or one of its member entities. The Com Laude Group is a limited company registered in England and Wales with company number 10689074 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England. The Com Laude Group includes Nom-IQ Limited t/a Com Laude, a company registered in England and Wales with company number 5047655 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Valideus Limited, a company registered in England and Wales with company number 6181291 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Demys Limited, a company registered in Scotland with company number SC197176 and registered office at 15 William Street, South West Lane, Edinburgh, EH3 7LL Scotland; Consonum, Inc. dba Com Laude USA and Valideus USA, a corporation incorporated in the State of Washington and principal office address at Suite 332, Securities Building, 1904 Third Ave, Seattle, WA 98101; Com Laude (Japan) Corporation, a company registered in Japan with company number 0100-01-190853 and registered office at 1-3-21 Shinkawa, Chuo-ku, Tokyo, 104-0033, Japan; Com Laude Domain ESP S.L.U., a company registered in Spain and registered office address at Calle Barcas 2, 2, Valencia, 46002, Spain. For further information see www.comlaude.com<https://comlaude.com>
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://mm.icann.org/pipermail/gnso-gac-closed-generics/attachments/20230406/7419e4b3/attachment-0001.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image002.png
Type: image/png
Size: 8673 bytes
Desc: image002.png
URL: <https://mm.icann.org/pipermail/gnso-gac-closed-generics/attachments/20230406/7419e4b3/image002-0001.png>